|Publication number||US3924641 A|
|Publication date||Dec 9, 1975|
|Filing date||Aug 19, 1974|
|Priority date||Aug 19, 1974|
|Publication number||US 3924641 A, US 3924641A, US-A-3924641, US3924641 A, US3924641A|
|Inventors||Gerhard T Weiss|
|Original Assignee||Axotronics Inc|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (5), Referenced by (82), Classifications (11), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent 1191 Weiss Dec. 9, 1975 Bl-PHASIC CURRENT STIMULATION Primary ExaminerRichard A. Gaudet SYSTEM Assistant ExaminerLee S. Cohen  Inventor; Gerhard Weiss, Northford Conn. Attorney, Agent, or Firm-Walter Spruegel  Assignee: Axotronics lnc., Hamden, Conn.
 ABSTRACT  Filed: Aug. 19, 1974 A circuit for producing current-controlled bi-phasic  PP No: 498,740 pulses to stimulate living tissue includes two conducting paths connected in parallel between high and low 52 US. Cl 128/419 PG; 128/421 W terminals with each of the csnducting PathS 51 1m. (:1. A61N l/36 havmg first and seem! switches in Series 5 Field f Search 128/42O, 421, 422 423, therein. The intersections of the respective first and 128/419 13, 419 C 419 E 419 G, 419 PG, second switches in each of the paths define output ter- 9 R minals across which bi-phasic pulses are produced. These output terminals include electrode members for 5 References Cited electrically attaching therlrli tto living tissutes. lrgerfcolrlinectin circuits connectt e irst switch 0 eac 0 t e UNITED STATES PATENTS condu ting paths with the second switch of the other LaVCZZT) conducting to respectively open and close the 2 a 419 P6 second switches in response to the first switches of op- 3:727:616 41973 1.5112122: izizi i i: posite paths being operfed and closed A digital 3,835,865 9/1974 Bowers 128/419 PG gramme alternately dm'es one of the first swltches Canada 128/419 R open and the other closed. Current controlling valves are connected in the paths between the low voltage terminal and the output terminals to selectively control current flow through the electrodes.
7 Claims, 2 Drawing Figures US. Patent Dec. 9, 1975 & mama VQZMGE /-4 BI-PHASIC CURRENT STIMULATION SYSTEM BACKGROUND OF THE INVENTION This invention relates broadly to the art of electronic stimulators and more particularly to devices for generating current controlled, bi-phasic pulses to stimulate areas of the brain, nerves, or other organs.
In behavioral research, stimulation of certain areas of the brain is often used to find ways to suppress intractable pain, aggressive behavior, or toexplore brain structures and their influence on the behavior of animals or humans. Brain stimulation is also applied in efforts to fight other disorders associated with the brain.
In addition to brain research, electrical stimulation is also widely used to restore proper functioning of various organs such as hearts, lungs, or bladders in cases where the control of these organs is disturbed because of disease, injury, or other causes.
The effects elicited by electrical stimulations are, to a large extent, determined by the amounts of current flow rather than by the magnitudes of applied voltages. Since the impedance between points of stimulation varies widely and may even change during stimulation, the current will also change even if the voltage is maintained at a constant level. This makes it difficult to control the amount of current flow. Thus, it is an object of this invention to provide an electrical stimulation circuit which provides an adjustable, controllable, stimulating current.
Further, if pulses of one polarity only are used for stimulation, electro/chemical effects tend to create unfavorable interactions between electrodes and tissues. Many researchers, therefore, prefer stimulation pulses in both polarities, such as with a negative pulse, followed immediately by a positive pulse, preferably each being of equal magnitude and duration. Thus, it is an object of this invention to provide an electrical circuit for providing such pulses.
Another object of this invention is to provide a circuit for generating bi-phasic, current-controlled pulses with current amplitudes of both negative and positive portions thereof being proportional to an applied control voltage.
Still another object of this invention is to provide a current controlled, bi-phasic or mono-phasic pulse generator whose output impedance is high enough to allow the use of its stimulation electrodes for measuring the response to stimulation, e.g. brain stimulation, EEG recordings and the like.
Still another object of this invention is to provide a circuit for generating bi-phasic or mono-phasic current controlled pulses, the characteristics of which are controlled by a programmer.
SUMMARY OF THE INVENTION first switch of the first path is interconnected to the second switch of the second path, and vice versa, to assure that the first and second switches of opposite paths are opened and closed together. A driving device alternately drives the first switch of the first path on or closed," and the first switch of the second path off,
2 or open, and vice versa. The driving mechanism measures the time period that the switches are in open and closed positions, Electronic valves are located in each of the first and second paths between the first voltage terminal and the output terminals to selectively control current flow to the electrodes.
BRIEF DESCRIPTION OF THE DRAWINGS The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of a preferred embodiment of the invention, as illustrated in the accompanying drawings in which reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention in a clear manner.
FIG. 1 is a schematic diagram of a current controlled, bi-phasis pulse generator employing principles of this invention; and
FIG. 2 is a diagrammatic representation of an output pulse of the bi-phasic pulse generator of FIG. 1.
DESCRIPTION OF THE PREFERRED EMBODIMENT The preferred embodiment of the pulse generator of this invention, illustrated in FIG. 1, comprises two first transistor switches 10 and 12, two second transistor switches 14 'and 16, a pair of current control valve devices 18 and 20, a digital programmer 22 and a control voltage generator 24. The pulse generator is energized by a +20 volts, positive voltage terminal 26 and a -20 volts, negative voltage terminal 28 and forms two parallel connected, main conducting paths 30 and 32 between these voltage terminals. In practice, a single 40 volt source could be used.
The first transistor switches 10 and 12 comprise PNP transistors Q1 and Q2 and 22K control resistors 34 and 36. The second transistor switches 14 and 16 comprise NPN transistors Q3 and Q4 and K control resistors 38 and 40, In this regard, the interconnection between the positive voltage terminal 26 and the base of the transistor Q1 via the resistor 34 holds transistor O1 in an off state when transistor Q4 is off and no current can flow through resistor 40. When transistor O4 is on, a current path is established from the positive voltage terminal 26 through both the Q1 base-to-emitter junction, and the resistor 34, the resistor 40, and the transistor O4 to the negative voltage terminal 28, thereby placing transistor O1 in an on state. There is a similar interaction between the resistors 36 and 38 and the transistors Q2 and Q3.
The first and second current control valve devices 18 and 20 respectively comprise NPN transistors Q5 and Q6 and series resistors 42 and 44.
In the preferred embodiment, the switching transistors Q1, Q2, Q3, and Q4 are chosen to operate, for practical purposes, in an on-off fashion while the current control transistors Q5 and Q6 are chosen to operate in a gradual manner for regulating current flow.
Electrodes 46 and 48, which are adapted to be electricallyattached to living tissue, are respectively electrically connected to the main conducting paths 30 and 32 between the transistor switch 10- and the first current control valve device 18 and between'the transistor switch 12 and thesecond current control valve device The digital programmer 22 is connected to the bases of the switching transistors Q3 and Q4 and selectively provides gating signals to these transistors. The digital programmer 22 also drives the control voltage generator 24 which, in turn, selectively produces steady-state control voltages at the bases of the first and second current control transistors Q and Q6.
Diodes 50 and 52 prevent excess reverse voltages from occurring between the bases and emitters of the current control transistors Q5 and Q6.
In operation, the electrodes 46 and 48 are connected to living tissue, such as nerves or other organs, either directly or indirectly. When it is desired to transmit biphasic pulses to the living tissue, the digital programmer 22 gates the switching transistor Q3 on and the switching transistor Q4 off for a time period of T1 and then gates the switching transistor Q4 on and switching transistor Q3 off for an identical time period T2.
During time period Tl, when the switching transistor Q3 is on, a current flow is established through the control resistors 36 and 38 to lower the potential appearing at the base of the switching transistor Q2. This places the switching transistor Q2 in an on mode of operation. Thus, a circuit is established between the positive voltage terminal 26 and the first electrode 46 through the switching transistor Q2. A circuit is also completed between the second electrode 48 and the negative voltage terminal 28 via the current control transistor Q5, the resistor 42, and diode 50, and the switching transistor Q3. Thus, a circuit is completed from the positive voltage terminal 26 to the negative voltage terminal 28 via living tissue connected to the electrodes 46 and 48. It should be noted that during time period T, both of the switching transistors Q4 and Q1 are locked in off modes.
During the time period T2 the switching transistor Q3 is turned off so that the voltage appearing at the base of the switching transistor Q2 rises to the voltage of the positive voltage terminal 26, which, in turn, turns off the switching transistor Q2. Thus, the electrode 46 is no longer connected to the high voltage terminal 26. However, the switching transistor Q4 is turned on by the digital programmer 22 so that the voltage at the base of the switching transistor Q1 rises to turn on this transistor. Thus, the electrode 48 is now in communication with the positive voltage terminal 26. Also, the other electrode 46 is now in communication with the negative voltage terminal 28 via the second current control device 20, the diode 52 and the switching transistor Q4. Thus, the polarities, and current flow, of the electrodes 46 and 48 have been reversed.
Before and after the time periods T1 and T2, the digital programmer does not place either the third or fourth switching transistors Q3 and Q4 in on modes of operation so that neither of the electrodes 46 and 48 are connected to the positive and negative voltage terminals 26 and 28. The output signal appearing at electrodes 46 and 48 before, after, and during the time periods T1 and T2 can be graphically represented as shown in FIG. 2.
In the preferred embodiment, the control voltage generator 24 provides steady-state control voltages ranging from 1.4 to 5 volts. It should be understood that the magnitude of a selected control voltage determines the magnitudes of current signals applied by the electrodes 46 and 48 to living tissue.
It should be further appreciated that the duration of the pulses can be accurately controlled by the digital programmer 22.
In addition, during periods of no pulses, since all four transistor switches are open, the electrodes 46 and 48 can be used for recording purposes.
While the invention has been particularly shown and described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention. For example, various voltage magnitudes at voltage terminals 26 and 28 could be employed and it is not necessary that one of the supply voltages be either negative or positive. With regard to voltage magni tude, the high voltage source limit is determined by the perimeters of the transistors chosen and/or by the maximum current which has to be driven through the highest expected load impedance. Further, the transistors could be replaced by other types of electrical valves.
The embodiment of the invention in which an exclusive property or privilege are claimed are defined as follows:
1. A bi-phasic pulse generator for producing pulses to stimulate living tissue comprising:
first and second voltage terminals having voltages of different magnitudes;
first and second conducting paths connected in parallel between said first and second voltage terminals, each of said first and second conducting paths including first and second switches connected in series, with said first switch being connected electrically closer to said first voltage terminal than said second switch and the intersections of said first and second switches in each of said paths defining output electrodes across which pulse-generator output bi-phasic pulses are produced;
interconnecting means for connecting said first switch of said first conducting path with said second switch of said second conducting path and said first switch of said second conducting path with said second switch of said first conducting path to respectively close and open said second switches in response to said first switches of opposite paths being opened and closed; and,
a driving means for alternately driving one of said first switches open and the other closed for a first predetermined time period, and vice versa for a second predetermined time period.
2. A bi-phasic pulse generator as in claim 1 wherein is further included current-control, valve means connected in each of said paths between said first voltage terminal and said output electrodes to thereby control the flow of current through said electrodes.
3. A bi-phasic pulse generator as in claim 2, wherein said switches and control means comprise transistors.
4. A bi-phasic pulse generator as claimed in claim 1, wherein said driving means comprises a programming circuit means for alternately driving said first switches in a programmed sequence.
5. A bi-phasic pulse generator as claimed in claim 1, wherein said output electrodes include means for electrically attaching said electrodes to living tissue.
6. A bi-phasic pulse generator for producing pulses to stimulate living tissuecomprising:
first and second voltage terminals having different voltage potentials thereon;
of said electrodes including electronic valve means for selectively controlling the magnitude of current flow between said first voltage terminal and both of said first and second electrodes; and a control means attached to said electronic valve means for selectively adjusting the flow of current through said valve means. 7. A bi-phasic pulse generator as claimed in claim 6 wherein said electronic valve means comprise transistors.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3523539 *||Feb 26, 1968||Aug 11, 1970||Hewlett Packard Co||Demand cardiac pacemaker and method|
|US3563247 *||Mar 14, 1968||Feb 16, 1971||Gen Electric||Bidirectional heart stimulator|
|US3589370 *||Jun 6, 1968||Jun 29, 1971||Medical Biolog Instrumentation||Electronic muscle stimulator|
|US3727616 *||Jun 15, 1971||Apr 17, 1973||Gen Dynamics Corp||Electronic system for the stimulation of biological systems|
|US3835865 *||Jul 7, 1972||Sep 17, 1974||Gen Electric||Body organ stimulator|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4170999 *||Jun 19, 1978||Oct 16, 1979||Biotronik Mess- Und Therapiegerate Gmbh & Co.||Demand pacer having reduced recovery time|
|US4233965 *||Jan 16, 1978||Nov 18, 1980||Cas Products, Inc.||Method and apparatus for the therapeutic treatment of living tissue|
|US4327322 *||Oct 6, 1980||Apr 27, 1982||Spatial Dynamics, Ltd.||Bidirectional current supply circuit|
|US4343312 *||Feb 5, 1981||Aug 10, 1982||Vitafin N.V.||Pacemaker output circuit|
|US4373531 *||Feb 5, 1981||Feb 15, 1983||Vitafin N.V.||Apparatus for physiological stimulation and detection of evoked response|
|US4402322 *||Mar 25, 1981||Sep 6, 1983||Medtronic, Inc.||Pacer output circuit|
|US4446870 *||Jun 1, 1979||May 8, 1984||Wing Thomas W||Electrical treatment method|
|US4543956 *||May 24, 1984||Oct 1, 1985||Cordis Corporation||Biphasic cardiac pacer|
|US4561426 *||Sep 27, 1984||Dec 31, 1985||Stewart David J||Magnetic biological device|
|US4726379 *||Nov 14, 1985||Feb 23, 1988||Cardiac Control Systems, Inc.||Cardiac pacer with switching circuit for isolation|
|US4800883 *||Apr 2, 1986||Jan 31, 1989||Intermedics, Inc.||Apparatus for generating multiphasic defibrillation pulse waveform|
|US4821723 *||Feb 27, 1987||Apr 18, 1989||Intermedics Inc.||Biphasic waveforms for defibrillation|
|US4846181 *||Oct 2, 1987||Jul 11, 1989||Staodynamics, Inc.||Soft tissue wound healing therapy utilizing pulsed electrical stimulation|
|US4926879 *||Sep 12, 1989||May 22, 1990||Sevrain-Tech, Inc.||Electro-tactile stimulator|
|US4958632 *||Mar 5, 1980||Sep 25, 1990||Medtronic, Inc.||Adaptable, digital computer controlled cardiac pacemaker|
|US5036850 *||Aug 25, 1989||Aug 6, 1991||Staodyn, Inc.||Biphasic pulse output stage for electronic stimulating device|
|US5069211 *||Aug 25, 1989||Dec 3, 1991||Staodyn, Inc.||Microprocessor controlled electronic stimulating device having biphasic pulse output|
|US5135478 *||May 10, 1989||Aug 4, 1992||Drug Delivery Systems Inc.||Multi-signal electrical transdermal drug applicator|
|US5276022 *||Nov 5, 1991||Jan 4, 1994||Jencap Research Ltd.||Hormone preparation and method|
|US5318593 *||Nov 18, 1991||Jun 7, 1994||Medtronic, Inc.||Multi-mode adaptable implantable pacemaker|
|US5328452 *||Feb 25, 1993||Jul 12, 1994||Drug Delivery Systems Inc.||Multi-signal electrical transdermal drug application|
|US5330512 *||Dec 28, 1992||Jul 19, 1994||Cardiac Pacemakers, Inc.||Electrode charge-neutral sensing of evoked ECG|
|US5385575 *||Sep 29, 1993||Jan 31, 1995||Angeion Corporation||Implantable cardioverter defibrillator having variable output capacitance|
|US5411528 *||Nov 19, 1992||May 2, 1995||Pacesetter, Inc.||Electrically programmable polarity connector for an implantable body tissue stimulator|
|US5425748 *||Aug 5, 1993||Jun 20, 1995||Ventritex, Inc.||Method and apparatus for cardiac defibrillation|
|US5447518 *||Aug 31, 1993||Sep 5, 1995||Ventritex, Inc.||Method and apparatus for phase related cardiac defibrillation|
|US5456690 *||Oct 14, 1993||Oct 10, 1995||Ventritex, Inc.||System and method for fractal pulse defibrillation|
|US5507781 *||Aug 18, 1994||Apr 16, 1996||Angeion Corporation||Implantable defibrillator system with capacitor switching circuitry|
|US5833712 *||Apr 21, 1995||Nov 10, 1998||Angeion Corporation||Implantable defibrillator system for generating a biphasic waveform|
|US5871506 *||Aug 19, 1996||Feb 16, 1999||Mower; Morton M.||Augmentation of electrical conduction and contractility by biphasic cardiac pacing|
|US6067470 *||Mar 5, 1998||May 23, 2000||Mower Family Chf Treatment Irrevocable Trust||System and method for multiple site biphasic stimulation to revert ventricular arrhythmias|
|US6136019 *||Jan 16, 1998||Oct 24, 2000||Mower Family Chf Treatment Irrevocable Trust||Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool|
|US6141586 *||May 26, 1998||Oct 31, 2000||Mower Family Chf Treatment Irrevocable Trust||Method and apparatus to allow cyclic pacing at an average rate just above the intrinsic heart rate so as to maximize inotropic pacing effects at minimal heart rates|
|US6141587 *||May 27, 1998||Oct 31, 2000||Mower Family Chf Treatment Irrevocable Trust||Augmentation of muscle contractility by biphasic stimulation|
|US6178351||Jan 11, 1999||Jan 23, 2001||The Mower Family Chf Treatment Irrevocable Trust||Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation|
|US6295470||Jan 14, 1999||Sep 25, 2001||The Mower Family Chf Treatment Irrevocable Trust||Antitachycardial pacing|
|US6332096||Feb 16, 2000||Dec 18, 2001||Mower Chf Treatment Irrevocable Trust||Augmentation of electrical conduction and contractility by biphasic cardiac pacing|
|US6337995||Nov 13, 2000||Jan 8, 2002||Mower Chf Treatment Irrevocable Trust||Atrial sensing and multiple site stimulation as intervention for atrial fibrillation|
|US6341235||Oct 18, 2000||Jan 22, 2002||Mower Chf Treatment Irrevocable Trust||Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool|
|US6343232||Oct 19, 2000||Jan 29, 2002||Mower Chf Treatment Irrevocable Trust||Augmentation of muscle contractility by biphasic stimulation|
|US6411845||Sep 5, 2000||Jun 25, 2002||Mower Chf Treatment Irrevocable Trust||System for multiple site biphasic stimulation to revert ventricular arrhythmias|
|US6411847||Sep 22, 2000||Jun 25, 2002||Morton M. Mower||Apparatus for applying cyclic pacing at an average rate just above the intrinsic heart rate|
|US6458157 *||Jul 29, 1998||Oct 1, 2002||Suaning Gregg Joergen||Retinal stimulator|
|US6895274||Aug 14, 2001||May 17, 2005||The Mower Family Chf Treatment Irrevocable Trust||Antitachycardial pacing|
|US7020526||May 16, 2002||Mar 28, 2006||Ruan Jin Zhao||Electronic gastro-intestinal stimulation device|
|US7203537||Jan 10, 2004||Apr 10, 2007||Mr3 Medical, Llc||System and method for breaking reentry circuits by cooling cardiac tissue|
|US7209782 *||Dec 13, 2004||Apr 24, 2007||Link Yu||Full-range electrotherapy unit with digital force modutator|
|US7228184 *||Feb 22, 2003||Jun 5, 2007||Chester Heath||Viral-inhibiting method|
|US7277749||Jan 15, 2004||Oct 2, 2007||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California||Treatments for snoring using injectable neuromuscular stimulators|
|US7440800||May 31, 2005||Oct 21, 2008||Mr3 Medical, Llc||System and method for managing detrimental cardiac remodeling|
|US7840264||Mar 30, 2007||Nov 23, 2010||Mr3 Medical, Llc||System and method for breaking reentry circuits by cooling cardiac tissue|
|US7852052||Feb 28, 2006||Dec 14, 2010||Medtronic, Inc.||Supply circuit for implantable medical devices|
|US7908003||Jun 15, 2007||Mar 15, 2011||Mr3 Medical Llc||System and method for treating ischemia by improving cardiac efficiency|
|US8019421||Sep 5, 2002||Sep 13, 2011||Metacure Limited||Blood glucose level control|
|US8244371||Mar 16, 2006||Aug 14, 2012||Metacure Limited||Pancreas lead|
|US8260416||Oct 31, 2007||Sep 4, 2012||Impulse Dynamics, N.V.||Electrical muscle controller|
|US8290585||Jan 21, 2002||Oct 16, 2012||Mr3 Medical, Llc||Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool|
|US8301247||Oct 31, 2007||Oct 30, 2012||Impulse Dynamics, N.V.||Electrical muscle controller|
|US8311629||Oct 18, 2006||Nov 13, 2012||Impulse Dynamics, N.V.||Electrical muscle controller|
|US8326416||Oct 25, 2010||Dec 4, 2012||Impulse Dynamics Nv||Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue|
|US8346363 *||Dec 27, 2005||Jan 1, 2013||Metacure Limited||Blood glucose level control|
|US8352031||May 24, 2007||Jan 8, 2013||Impulse Dynamics Nv||Protein activity modification|
|US8447399||Apr 1, 2008||May 21, 2013||Mr3 Medical, Llc||System and method for managing detrimental cardiac remodeling|
|US8548583||May 4, 2006||Oct 1, 2013||Impulse Dynamics Nv||Protein activity modification|
|US8666495||Mar 18, 2005||Mar 4, 2014||Metacure Limited||Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar|
|US8700161||Sep 4, 2003||Apr 15, 2014||Metacure Limited||Blood glucose level control|
|US8792985||Jan 20, 2006||Jul 29, 2014||Metacure Limited||Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar|
|US8825152||Apr 3, 2002||Sep 2, 2014||Impulse Dynamics, N.V.||Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue|
|US8934975||Feb 1, 2011||Jan 13, 2015||Metacure Limited||Gastrointestinal electrical therapy|
|US9101765||Feb 16, 2006||Aug 11, 2015||Metacure Limited||Non-immediate effects of therapy|
|US9289618||Oct 23, 2001||Mar 22, 2016||Impulse Dynamics Nv||Electrical muscle controller|
|US20020099413 *||Jan 21, 2002||Jul 25, 2002||Mower Morton M.|
|US20040153127 *||Jan 15, 2004||Aug 5, 2004||Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ||Treatments for snoring using injectable neuromuscular stimulators|
|US20040167589 *||Feb 22, 2003||Aug 26, 2004||Chester Heath||Viral-inhibiting apparatus and methods|
|US20060129208 *||Dec 13, 2004||Jun 15, 2006||Link Yu||Full-range electrotherapy unit with digital force modulator|
|US20070073372 *||Nov 8, 2006||Mar 29, 2007||Chester Heath||Viral-inhibiting apparatus and methods|
|US20070203528 *||Feb 28, 2006||Aug 30, 2007||Vernon Scott D||Supply circuit for implantable medical devices|
|EP0052247A2 *||Oct 20, 1981||May 26, 1982||Torben Ejsing Dr. Jorgensen||Arrangement for the electrical stimulation of bones in the region of fracture|
|EP0052247A3 *||Oct 20, 1981||Sep 15, 1982||Torben Ejsing Dr. Jorgensen||Arrangement for the electrical stimulation of bones|
|EP0154976A1 *||Mar 12, 1985||Sep 18, 1985||BIO-RESEARCH ASSOCIATES, Inc.||Electrical muscle stimulator|
|EP1064048B1 *||Jan 13, 1999||Oct 20, 2004||Morton M. Mower||Augmentation of electrical conduction and contractibility by biphasic cardiac pacing administered via the cardiac blood pool|
|WO1999044682A1 *||Mar 4, 1999||Sep 10, 1999||Mower Morton M||System and method for multiple site biphasic stimulation to revert ventricular arrhythmias|
|U.S. Classification||607/74, 607/40, 607/46, 607/42, 607/45, 607/9|
|Cooperative Classification||A61N1/36021, A61N1/36025|
|European Classification||A61N1/36E, A61N1/36|
|May 7, 1990||AS||Assignment|
Owner name: VENTRITEX, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AXOTRONICS, INC., A CORP. OF CT.;REEL/FRAME:005289/0451
Effective date: 19900420
|May 7, 1990||AS02||Assignment of assignor's interest|
Owner name: AXOTRONICS, INC., A CORP. OF CT.
Effective date: 19900420
Owner name: VENTRITEX, INC., 709 EVELYN AVE., SUNNYVALE, CA. 9